Screener
Vaxcyte, Inc. PCVX Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001649094-26-000017
| Line item | March 31,2026 | December 31, 2025 |
|---|---|---|
| Operating lease right-of-use assets | 113,103 | 116,009 |
| Long-term investments | 1,004,017 | 881,664 |
| Restricted cash | 1,466 | 1,466 |
| Other assets | 155,539 | 118,847 |
| Total noncurrent assets | 1,534,820 | 1,375,356 |
| Total assets | $3,348,308 | $3,002,717 |
| Liabilities and Stockholders' Equity | ||
| Current liabilities: |
Item 1. Condensed Consolidated Financial Statements (unaudited)
FAQ
- What is Vaxcyte, Inc.'s other non-current assets?
- Vaxcyte, Inc. (PCVX) reported other non-current assets of $155.54M in Q1 2026.
- How has Vaxcyte, Inc.'s other non-current assets changed year-over-year?
- Vaxcyte, Inc.'s other non-current assets increased by 103.9% year-over-year, from $76.28M to $155.54M.
- What is the long-term trend for Vaxcyte, Inc.'s other non-current assets?
- Over 5 years (2020 to 2025), Vaxcyte, Inc.'s other non-current assets has grown at a 193.0% compound annual growth rate (CAGR), from $550K to $118.85M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Vaxcyte, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude